Search Results - "Iossa, D"

Combining VITEK® 2 with colistin agar dilution screening assist timely reporting of colistin susceptibility by Lellouche, J., Schwartz, D., Elmalech, N., Ben Dalak, M.A., Temkin, E., Paul, M., Geffen, Y., Yahav, D., Eliakim-Raz, N., Durante-Mangoni, E., Iossa, D., Bernardo, M., Daikos, G.L., Skiada, A., Pantazatou, A., Antoniadou, A., Mouton, J.W., Carmeli, Y., Nutman, A., Cohen-Percia, S., Daitch, V., Babich, T., Andini, R., Cuccurullo, S., Cristinziano, A., Cavezza, G., Bertolino, L., Giuffrè, G., Giurazza, R., Mallardo, E., Zampino, R.

“…The rise in carbapenem resistance among Gram-negative bacteria has renewed interest in colistin. Recently, the EUCAST-CLSI Polymyxin Breakpoints Working Group…”
Get full text

Efficacy and safety of tenofovir, entecavir, and telbivudine for chronic hepatitis B in heart transplant recipients by Durante-Mangoni, E., Vitrone, M., Parrella, A., Andini, R., Iossa, D., Ragone, E., Falco, E., Maiello, C., Utili, R., Zampino, R.

“…Background Treatment of chronic hepatitis B (CHB) with polymerase inhibitors is key to prevent disease flares and progression toward advanced liver disease…”
Get full text

812 DIFFERENTIAL EFFECT OF PEGYLATED INTERFERON alpha 2a AND alpha 2b ON THE EARLY HEPATITIS C VIRUS KINETICS by Durante-Mangoni, E, Pinto, D, Battimelli, C, Farinaro, V, Savinelli, C, Senese, A, Iorio, V, Graziano, C, Iossa, D, Molaro, R, Sodano, G, Utili, R

Get full text

1148 EFFECT OF THE IL28B SINGLE NUCLEOTIDE POLYMORPHISM (SNP) ON THE FIRST PHASE HEPATITIS C VIRUS KINETICS IN PATIENTS TREATED WITH PEG-INTERFERON AND RIBAVIRIN (PR) by Durante-Mangoni, E, Pinto, D, Battimelli, C, Farinaro, V, Savinelli, C, Senese, A, Iorio, V, Graziano, C, Iossa, D, Molaro, R, Sodano, G, Utili, R

Get full text

608 PEGINTERFERON-RIBAVIRIN TREATMENT IS SAFE AND EFFECTIVE IN HEPATITIS C PATIENTS WITH PRE-EXISTING HEART DISEASE by Durante-Mangoni, E, Iossa, D, Pinto, D, Utili, R

Get full text

Outcome of Treatment With Pegylated Interferon and Ribavirin in Heart Transplant Recipients With Chronic Hepatitis C by Durante-Mangoni, E, Ragone, E, Pinto, D, Iossa, D, Covino, F.E, Maiello, C, Utili, R

“…Abstract Background/aim The combination of pegylated interferon (PEG-IFN) and ribavirin (RBV) is the current treatment for chronic hepatitis C (CHC). The…”
Get full text

T-04 Effect of the IL28B single nucleotide polymorphism (SNP) on the first phase hepatitis C virus kinetics in patients treated with PEG-IFN/RBV by Durante-Mangoni, E, Pinto, D, Agrusta, F, Battimelli, C, Farinaro, V, Savinelli, C, Senese, A, Iorio, V, Graziano, C, Iossa, D, Molaro, R, Sodano, G, Utili, R

Get full text

F-07 Differential effect of pegylated interferon alpha 2a and alpha 2b on the early hepatitis C virus kinetics by Durante-Mangoni, E, Pinto, D, Agrusta, F, Battimelli, C, Farinaro, V, Savinelli, C, Senese, A, Iorio, V, Graziano, C, Iossa, D, Molaro, R, Sodano, G, Utili, R

Get full text

P31 PROSPECTIVE STUDY OF CARDIAC IMPLANTABLE ELECTRONIC DEVICE INFECTIVE ENDOCARDITIS by Mattucci, I, Iossa, D, Senese, A, Molaro, R, D'Amico, F, Pinto, D, Agrusta, F, Malgeri, U, Andini, R, Cesaro, F, Farinaro, V, Iorio, V, Cavezza, G, Graziano, C, Battimelli, C, Savinelli, C, Trojaniello, C, Baiano Svizzero, G, Utili, R, Durante-Mangoni, E

Get full text

P26 HOMOCYSTEINE IN INFECTIVE ENDOCARDITIS by Iossa, D, Molaro, R, D'Amico, F, Pinto, D, Agrusta, F, Mattucci, I, Malgeri, U, Andini, R, Cesaro, F, Senese, A, Farinaro, V, Iorio, V, Cavezza, G, Graziano, C, Battimelli, C, Savinelli, C, Trojaniello, C, Baiano Svizzero, G, Utili, R, Durante-Mangoni, E

Get full text

645 CORRELATES AND PROGNOSTIC VALUE OF HEPATITIS C VIRUS CORE ANTIGEN SERUM LEVELS DURING CHRONIC INFECTION AND TREATMENT by Durante-Mangoni, E, Vallefuoco, L, Perna, E, Iossa, D, Andini, R, Malgeri, U, Utili, R, Portella, G

Get full text

Safety and efficacy of peginterferon-ribavirin treatment in hepatitis C patients with heart disease by Durante-Mangoni, E, Iossa, D, Pinto, D, Utili, R

Get full text

041 INFECTIVE ENDOCARDITIS ON CARDIAC RHYTHM MANAGEMENT DEVICES: PRELIMINARY STUDY ON THE POSSIBLE PATHOGENIC ROLE OF INHERITED THROMBOPHILIAS by Durante-Mangoni, E, Brugnone, R, Iossa, D, Molaro, R, Crispi, F, Albisinni, R, Caprioli, V, Utili, R

Get full text

077 CLINICAL SIGNIFICANCE AND PROGNOSTIC VALUE OF N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE (NT-pro-BNP) IN INFECTIVE ENDOCARDITIS: A PRELIMINARY STUDY by Durante-Mangoni, E, Pinto, D, Iossa, D, Caianiello, C, Molaro, R, Casillo, R, Crispi, F, Ragone, E, Dialetto, G, Utili, R

Get full text

Influence of vancomycin minimum inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus left-sided infective endocarditis treated with antistaphylococcal β-lactam antibiotics: a prospective cohort study by the International Collaboration on Endocarditis by Pericàs, J.M., Garcia-de-la-Mària, C., Sharma-Kuinkel, B.K., Marco, F., Wray, D., Kanafani, Z.A., Tattevin, P., Chu, V.H., Fowler, V.G., Harris, O., Korman, T.M., Kotsanas, D., Jones, P., Reinbott, P., Ryan, S., Fortes, C.Q., Garcia, P., Jones, S.B., Barsic, B., Bukovski, S., Delahaye, F., Vandenesch, F., Tattevin, P., Hoen, B., Plesiat, P., Giamarellou, H., Tarpatzi, E., Durante-Mangoni, E., Iossa, D., Ursi, M.P., Pafundi, P.C., D' Amico, F., Bernardo, M., Cuccurullo, S., Dialetto, G., Manduca, S., Della Corte, A., Tripodi, M.F., Baban, T., Kanafani, Z.A., Yasmine, M., Morris, A., Premru, M.M., Lejko-Zupanc, T., Almela, M., Ambrosioni, J., Azqueta, M., Brunet, M., Cervera, C., Falces, C., Fuster, D., Garcia-de-la-Mària, C., Garcia-Gonzalez, J., Gatell, J.M., Marco, F., Ortiz, J., Ninot, S., Paré, J.C., Pericas, J.M., Quintana, E., Ramirez, J., Sandoval, E., Sitges, M., Tolosana, J.M., Vidal, B., Vila, J., Rodríguez-Créixems, M., Ramallo, V., Wray, D., Steed, L., Cantey, R., Peterson, G., Stancoven, A., Woods, C., Corey, G.R., Reller, L.B., Fowler, V.G., Baloch, K., Chu, V.H., Corey, G.R., Dixon, C.C., Fowler, V.G., Harding, T., Jones-Richmond, M., Pappas, P., Park, L.P., Redick, T., Stafford, J., Anstrom, K., Bayer, A.S., Hoen, B., Karchmer, A.W., Miró, J.M., Murdoch, D.R., Sexton, D.J., Wang, A., Chu, V., Olaison, L., Raoult, D., Rubinstein, E.

“…Left-sided methicillin-susceptible Staphylococcus aureus (MSSA) endocarditis treated with cloxacillin has a poorer prognosis when the vancomycin minimum…”
Get full text